Refine by
Disease Target Articles & Analysis: This-Year
4 articles found
Idiopathic pulmonary fibrosis (IPF) remains a challenging respiratory disease characterized by progressive lung scarring, with current therapies only slowing disease progression. A 2026 study of human and animal models identifies concurrent inhibition of the transcription regulators ID1 and ID3 as a potential therapeutic approach, given their upregulation in ...
By enhancing immunogenicity, peptides help create more effective vaccines that provide better disease protection. Peptide Vaccines for Infectious DiseasesPeptide vaccines open new avenues for combating infectious diseases. ...
Applications of Transcriptome Analysis The wide application of transcriptomics in biomedical research is of great significance in understanding the basic mechanisms of life, revealing the molecular mechanisms of disease development, and discovering new therapeutic targets and drugs, including the following directions: Analysis of Gene Expression Regulation l ...
In June 2025, Capstan Therapeutics announced the initiation of a Phase I clinical trial for CPTX2309, an in vivo CAR-T candidate targeting B-cell–mediated autoimmune diseases. The therapy uses targeted lipid nanoparticles (tLNPs) to deliver CAR-encoding mRNA directly to immune cells. ...